Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ERCC6L WRN CHD1L TOP6BL RFC1 CHD5 SHPRH	1.11e-05	127	119	7	GO:0008094
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ERCC6L CHD1L CHD5 SHPRH	6.80e-05	37	119	4	GO:0140658
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERCC6L WRN CHD1L TOP6BL RFC1 XRCC4 CHD5 SHPRH	1.77e-04	262	119	8	GO:0140097
GeneOntologyMolecularFunction	histone deacetylase binding	MAGEA3 MAGEA6 NRIP1 NACC1 NACC2 CHD5	2.52e-04	147	119	6	GO:0042826
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 ERCC6L KIF26A KIF26B WRN CHD1L TOP6BL RFC1 STARD9 RALBP1 CHD5 SHPRH	3.05e-04	614	119	12	GO:0140657
Domain	BEN	NACC1 BEND2 NACC2	1.91e-05	9	116	3	PF10523
Domain	BEN_domain	NACC1 BEND2 NACC2	1.91e-05	9	116	3	IPR018379
Domain	BEN	NACC1 BEND2 NACC2	1.91e-05	9	116	3	PS51457
Domain	BEN	NACC1 BEND2 NACC2	1.91e-05	9	116	3	SM01025
Domain	FN3	SDK2 DSCAM ABI3BP DCC CMYA5 IFNAR1 IGF1R PTPRC	2.03e-05	185	116	8	SM00060
Domain	FN3	SDK2 DSCAM ABI3BP DCC CMYA5 IFNAR1 IGF1R PTPRC	3.43e-05	199	116	8	PS50853
Domain	MAGEA3/MAGEA6	MAGEA3 MAGEA6	3.82e-05	2	116	2	IPR030097
Domain	SNF2_N	ERCC6L CHD1L CHD5 SHPRH	4.44e-05	32	116	4	IPR000330
Domain	SNF2_N	ERCC6L CHD1L CHD5 SHPRH	4.44e-05	32	116	4	PF00176
Domain	FN3_dom	SDK2 DSCAM ABI3BP DCC CMYA5 IFNAR1 IGF1R PTPRC	4.86e-05	209	116	8	IPR003961
Domain	fn3	SDK2 DSCAM ABI3BP DCC CMYA5 IGF1R PTPRC	6.85e-05	162	116	7	PF00041
Domain	G_patch	RBM10 AGGF1 GPATCH8	3.78e-04	23	116	3	SM00443
Domain	G_patch_dom	RBM10 AGGF1 GPATCH8	3.78e-04	23	116	3	IPR000467
Domain	G_PATCH	RBM10 AGGF1 GPATCH8	3.78e-04	23	116	3	PS50174
Domain	G-patch	RBM10 AGGF1 GPATCH8	3.78e-04	23	116	3	PF01585
Domain	Helicase_C	ERCC6L WRN CHD1L CHD5 SHPRH	5.44e-04	107	116	5	PF00271
Domain	HELICc	ERCC6L WRN CHD1L CHD5 SHPRH	5.44e-04	107	116	5	SM00490
Domain	Alpha_kinase	ALPK1 ALPK2	5.64e-04	6	116	2	PF02816
Domain	ALPHA_KINASE	ALPK1 ALPK2	5.64e-04	6	116	2	PS51158
Domain	Alpha_kinase	ALPK1 ALPK2	5.64e-04	6	116	2	SM00811
Domain	MHCK_EF2_kinase	ALPK1 ALPK2	5.64e-04	6	116	2	IPR004166
Domain	Helicase_C	ERCC6L WRN CHD1L CHD5 SHPRH	5.68e-04	108	116	5	IPR001650
Domain	HELICASE_CTER	ERCC6L WRN CHD1L CHD5 SHPRH	5.92e-04	109	116	5	PS51194
Domain	HELICASE_ATP_BIND_1	ERCC6L WRN CHD1L CHD5 SHPRH	5.92e-04	109	116	5	PS51192
Domain	DEXDc	ERCC6L WRN CHD1L CHD5 SHPRH	5.92e-04	109	116	5	SM00487
Domain	Helicase_ATP-bd	ERCC6L WRN CHD1L CHD5 SHPRH	6.17e-04	110	116	5	IPR014001
Domain	Ig-like_fold	LILRB3 SDK2 DSCAM ABI3BP LAIR1 DCC CMYA5 IFNAR1 IGF1R PTPRC SIGLEC11 ALPK2	1.47e-03	706	116	12	IPR013783
Domain	DEAH_ATP_HELICASE	WRN CHD1L CHD5	1.68e-03	38	116	3	PS00690
Domain	Znf_FYVE_PHD	NSD2 KAT6A CHD5 SHPRH RIMS2	2.25e-03	147	116	5	IPR011011
Domain	PHD	NSD2 KAT6A CHD5 SHPRH	2.30e-03	89	116	4	SM00249
Domain	Oxysterol-bd	OSBPL3 OSBPL6	2.42e-03	12	116	2	IPR000648
Domain	Oxysterol-bd_CS	OSBPL3 OSBPL6	2.42e-03	12	116	2	IPR018494
Domain	Oxysterol_BP	OSBPL3 OSBPL6	2.42e-03	12	116	2	PF01237
Domain	OSBP	OSBPL3 OSBPL6	2.42e-03	12	116	2	PS01013
Domain	Znf_PHD	NSD2 KAT6A CHD5 SHPRH	2.49e-03	91	116	4	IPR001965
Domain	KINESIN_MOTOR_1	KIF26A KIF26B STARD9	2.57e-03	44	116	3	PS00411
Domain	-	KIF26A KIF26B STARD9	2.57e-03	44	116	3	3.40.850.10
Domain	Kinesin_motor_dom	KIF26A KIF26B STARD9	2.57e-03	44	116	3	IPR001752
Domain	Kinesin	KIF26A KIF26B STARD9	2.57e-03	44	116	3	PF00225
Domain	KINESIN_MOTOR_2	KIF26A KIF26B STARD9	2.57e-03	44	116	3	PS50067
Domain	KISc	KIF26A KIF26B STARD9	2.57e-03	44	116	3	SM00129
Domain	-	SDK2 DSCAM ABI3BP LAIR1 DCC CMYA5 IFNAR1 IGF1R PTPRC SIGLEC11 ALPK2	2.79e-03	663	116	11	2.60.40.10
Domain	H15	KAT6A SHPRH	2.85e-03	13	116	2	SM00526
Domain	H15	KAT6A SHPRH	2.85e-03	13	116	2	PS51504
Domain	ZF_PHD_2	NSD2 KAT6A CHD5 SHPRH	2.91e-03	95	116	4	PS50016
Domain	ZF_PHD_1	NSD2 KAT6A CHD5 SHPRH	3.02e-03	96	116	4	PS01359
Domain	-	CDC42BPA FRS3 ARHGEF12 APPL2 OSBPL3 OSBPL6 ROCK1 MAPK8IP2	3.06e-03	391	116	8	2.30.29.30
Domain	Histone_H1/H5_H15	KAT6A SHPRH	3.31e-03	14	116	2	IPR005818
Domain	PH_dom-like	CDC42BPA FRS3 ARHGEF12 APPL2 OSBPL3 OSBPL6 ROCK1 MAPK8IP2	5.12e-03	426	116	8	IPR011993
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	FNBP1 NRIP1 MIA3 CDC42BPA ANK3 NRF1 NSD2 KAT6A AFF3 SHB CHD1L PFKFB4 ZNF462 YEATS2 PPARGC1B IGF1R NACC2 RIN2 SHPRH NTN1 ZFHX3 TTC17 ANKRD12 PCM1	2.50e-10	1489	120	24	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDC42BPA ERCC6L KIF26B PARP8 CCDC18 ALPK1 INPP5F PPM1A USP8 IGF1R OSBPL3 STARD9 OSBPL6 EDRF1 PCM1 DOP1B	4.89e-08	861	120	16	36931259
Pubmed	Coordinated interaction of Down syndrome cell adhesion molecule and deleted in colorectal cancer with dynamic TUBB3 mediates Netrin-1-induced axon branching.	DSCAM DCC NTN1	1.60e-07	4	120	3	25754961
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	NACC1 NSD2 KAT6A WRN CHD1L GPATCH8 RFC1 EMSY ZNF462 ZNF451 CHD5 SHPRH SMARCB1	1.99e-07	608	120	13	36089195
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 NRIP1 DCHS2 ANK3 DSCAM EFEMP2 APC2 CMYA5 USP8 APPL2 HEY1 RALBP1 ZNF451 RNF216 TTC17 PCM1 MAPK8IP2 DOP1B	4.50e-07	1285	120	18	35914814
Pubmed	DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1.	DSCAM DCC NTN1	7.95e-07	6	120	3	18585357
Pubmed	Genetic analysis of DSCAM's role as a Netrin-1 receptor in vertebrates.	DSCAM DCC NTN1	7.95e-07	6	120	3	22238077
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FNBP1 RBM10 ARHGEF12 GPATCH8 YEATS2 USP8 STARD9 ZNF451 ANKRD12 DOP1B	1.60e-06	407	120	10	12693553
Pubmed	Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration.	ERCC6L RFC1 CLSPN	6.48e-06	11	120	3	21425081
Pubmed	Altered midline axon pathways and ectopic neurons in the developing hypothalamus of netrin-1- and DCC-deficient mice.	DCC CD44 NTN1	1.12e-05	13	120	3	10559399
Pubmed	miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.	MAGEA3 MAGEA6	1.18e-05	2	120	2	30056111
Pubmed	Netrin induces down-regulation of its receptor, Deleted in Colorectal Cancer, through the ubiquitin-proteasome pathway in the embryonic cortical neuron.	DCC NTN1	1.18e-05	2	120	2	16181408
Pubmed	Netrin-1-like-immunoreactivity Coexpresses With DCC and Has a Differential Level in the Myenteric Cholinergic and Nitrergic Neurons of the Adult Mouse Colon.	DCC NTN1	1.18e-05	2	120	2	30576266
Pubmed	A Novel Netrin-1-Derived Peptide Enhances Protection against Neuronal Death and Mitigates of Intracerebral Hemorrhage in Mice.	DCC NTN1	1.18e-05	2	120	2	34063230
Pubmed	Biallelic mutations in human DCC cause developmental split-brain syndrome.	DCC NTN1	1.18e-05	2	120	2	28250456
Pubmed	Spatio-temporal deleted in colorectal cancer (DCC) and netrin-1 expression in human foetal brain development.	DCC NTN1	1.18e-05	2	120	2	20609112
Pubmed	Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy.	DCC NTN1	1.18e-05	2	120	2	24928309
Pubmed	An imbalance of netrin-1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease.	DCC NTN1	1.18e-05	2	120	2	36852451
Pubmed	Deleted in Colorectal Cancer (DCC) encodes a netrin receptor.	DCC NTN1	1.18e-05	2	120	2	8861902
Pubmed	Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis.	DCC NTN1	1.18e-05	2	120	2	15491747
Pubmed	Activity-Dependent Netrin-1 Secretion Drives Synaptic Insertion of GluA1-Containing AMPA Receptors in the Hippocampus.	DCC NTN1	1.18e-05	2	120	2	30282026
Pubmed	DCC/netrin-1 regulates cell death in oligodendrocytes after brain injury.	DCC NTN1	1.18e-05	2	120	2	36456775
Pubmed	Dscam guides embryonic axons by Netrin-dependent and -independent functions.	DSCAM NTN1	1.18e-05	2	120	2	18948420
Pubmed	Encephalomyocarditis virus induces PKR-independent mitogen-activated protein kinase activation in macrophages.	IFNAR1 EIF2AK2	1.18e-05	2	120	2	16051816
Pubmed	Netrin-1 - DCC Signaling Systems and Age-Related Macular Degeneration.	DCC NTN1	1.18e-05	2	120	2	25950802
Pubmed	DCC functions as an accelerator of thalamocortical axonal growth downstream of spontaneous thalamic activity.	DCC NTN1	1.18e-05	2	120	2	25947198
Pubmed	Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF.	ARHGEF12 IGF1R	1.18e-05	2	120	2	11724822
Pubmed	Netrin-1 is a survival factor during commissural neuron navigation.	DCC NTN1	1.18e-05	2	120	2	18796601
Pubmed	Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas.	DCC NTN1	1.18e-05	2	120	2	9950216
Pubmed	Increased expression of netrin-1 and its deleted in colorectal cancer receptor in human diseased lumbar intervertebral disc compared with autopsy control.	DCC NTN1	1.18e-05	2	120	2	22588384
Pubmed	DCC/NTN1 complex mutations in patients with congenital hypogonadotropic hypogonadism impair GnRH neuron development.	DCC NTN1	1.18e-05	2	120	2	29202173
Pubmed	Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.	BEND2 MN1	1.18e-05	2	120	2	36604386
Pubmed	Plasmacytoid Dendritic Cells Provide Protection Against Bacterial-Induced Colitis.	IFNAR1 PTPRC	1.18e-05	2	120	2	31024525
Pubmed	Acetylcholine synergizes with netrin-1 to drive persistent firing in the entorhinal cortex.	DCC NTN1	1.18e-05	2	120	2	38377003
Pubmed	IFNAR1 controls progression to cerebral malaria in children and CD8+ T cell brain pathology in Plasmodium berghei-infected mice.	IFNAR1 PTPRC	1.18e-05	2	120	2	23585679
Pubmed	Molecular guidance cues necessary for axon pathfinding from the ventral cochlear nucleus.	DCC NTN1	1.18e-05	2	120	2	17701984
Pubmed	Association of increased genotypes risk for bipolar disorder with brain white matter integrity investigated with tract-based spatial statistics: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summarise relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.	ANK3 ZNF804A	1.18e-05	2	120	2	28648753
Pubmed	ANK3 rs10994336 and ZNF804A rs7597593 polymorphisms: genetic interaction for emotional and behavioral symptoms of alcohol withdrawal syndrome.	ANK3 ZNF804A	1.18e-05	2	120	2	38702695
Pubmed	Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson's disease features.	DCC NTN1	1.18e-05	2	120	2	33351190
Pubmed	Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice.	IFNAR1 EIF2AK2	1.18e-05	2	120	2	16760403
Pubmed	DCC association with lipid rafts is required for netrin-1-mediated axon guidance.	DCC NTN1	1.18e-05	2	120	2	15811950
Pubmed	A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.	MAGEA3 MAGEA6	1.18e-05	2	120	2	25564441
Pubmed	CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.	PFKFB4 CD44	1.18e-05	2	120	2	30613295
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	NSD2 CCDC18 CHD1L RFC1 XRCC4 GPALPP1 SHPRH SLBP ROCK1 EDRF1 PCM1	1.53e-05	645	120	11	25281560
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 NRIP1 NACC1 INPP5F ZNF462 YEATS2 KIAA1958 ZFHX3 PCM1	1.55e-05	418	120	9	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 SDK2 CDC42BPA SZT2 KIF26A NSD2 SANBR INPP5F CHD5 RIMS2	1.59e-05	529	120	10	14621295
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FNBP1 ERCC6L NACC1 RBM10 GPATCH8 RFC1 EMSY YEATS2 PTPRC KIAA1958 MN1 PCM1	1.59e-05	774	120	12	15302935
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	NRIP1 BNC2 RBM10 CHD1L PPM1A ZNF462 OSBPL3 RALBP1 NTN1 ZFHX3	1.77e-05	536	120	10	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	NRIP1 BNC2 RBM10 CHD1L PPM1A ZNF462 OSBPL3 RALBP1 NTN1 ZFHX3	1.83e-05	538	120	10	10512203
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	NRIP1 NACC1 EMSY ZNF462 YEATS2 SMARCB1	2.60e-05	167	120	6	20362541
Pubmed	Analysis of Expression Pattern and Genetic Deletion of Netrin5 in the Developing Mouse.	DSCAM DCC NTN1	2.63e-05	17	120	3	26858598
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MIA3 ANK3 DSCAM NACC1 APC2 ARHGEF12 SPECC1L EMSY ZNF462 OSBPL3 ROCK1 PCM1 MAPK8IP2	2.96e-05	963	120	13	28671696
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 NACC1 NSD2 TPRN KAT6A DCAF16 YEATS2 OSBPL3 CHD5 SMARCB1 ZFHX3 CLSPN PCM1 BAHCC1	3.21e-05	1116	120	14	31753913
Pubmed	Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration.	BEND2 MN1	3.53e-05	3	120	2	31863478
Pubmed	Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor.	DCC NTN1	3.53e-05	3	120	2	18922894
Pubmed	CD45 down-regulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells.	PTPRC CD44	3.53e-05	3	120	2	18981123
Pubmed	A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization.	NRIP1 PPARGC1B	3.53e-05	3	120	2	22923471
Pubmed	Netrin-1 acts as a survival factor via its receptors UNC5H and DCC.	DCC NTN1	3.53e-05	3	120	2	11387206
Pubmed	miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.	PPARGC1B IGF1R	3.53e-05	3	120	2	26868851
Pubmed	Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.	IFNAR1 EIF2AK2	3.53e-05	3	120	2	10801979
Pubmed	Macrophage-derived netrin-1 drives adrenergic nerve-associated lung fibrosis.	DCC NTN1	3.53e-05	3	120	2	33393489
Pubmed	Mapping netrin receptor binding reveals domains of Unc5 regulating its tyrosine phosphorylation.	DCC NTN1	3.53e-05	3	120	2	15574733
Pubmed	Diffusion tensor magnetic resonance imaging and tract-tracing analysis of Probst bundle structure in Netrin1- and DCC-deficient mice.	DCC NTN1	3.53e-05	3	120	2	17898206
Pubmed	Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling.	IFNAR1 PTPRC	3.53e-05	3	120	2	26077719
Pubmed	Characterization and expression of netrin-1 and its receptors UNC5B and DCC in human placenta.	DCC NTN1	3.53e-05	3	120	2	19826074
Pubmed	Congenital Mirror Movements	DCC NTN1	3.53e-05	3	120	2	25763452
Pubmed	Netrin-1 and its receptors in tumorigenesis.	DCC NTN1	3.53e-05	3	120	2	15573119
Pubmed	Possible Role of Netrin-1/Deleted in Colorectal Cancer/Vascular Endothelial Growth Factor Signaling Pathway in the Pathogenesis of Placenta Accreta Spectrum: A Case-control Study.	DCC NTN1	3.53e-05	3	120	2	38289148
Pubmed	The netrin 1 receptors Unc5h3 and Dcc are necessary at multiple choice points for the guidance of corticospinal tract axons.	DCC NTN1	3.53e-05	3	120	2	12451134
Pubmed	ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype.	ANK3 ZNF804A	3.53e-05	3	120	2	21767209
Pubmed	Characterization of leukemia-associated Rho guanine nucleotide exchange factor (LARG) expression during murine development.	ARHGEF12 IGF1R	3.53e-05	3	120	2	14513355
Pubmed	Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression.	DCC NTN1	3.53e-05	3	120	2	19721007
Pubmed	Phosphorylation of DCC by Fyn mediates Netrin-1 signaling in growth cone guidance.	DCC NTN1	3.53e-05	3	120	2	15557120
Pubmed	DSCAM functions as a netrin receptor in commissural axon pathfinding.	DSCAM NTN1	3.53e-05	3	120	2	19196994
Pubmed	Subfamily III of mammalian oxysterol-binding protein (OSBP) homologues: the expression and intracellular localization of ORP3, ORP6, and ORP7.	OSBPL3 OSBPL6	3.53e-05	3	120	2	14593528
Pubmed	DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function.	WRN IFNAR1	3.53e-05	3	120	2	25921537
Pubmed	Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome.	DCC NTN1	3.53e-05	3	120	2	16280635
Pubmed	Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor.	DCC NTN1	3.53e-05	3	120	2	11048721
Pubmed	Resilience to amphetamine in mouse models of netrin-1 haploinsufficiency: role of mesocortical dopamine.	DCC NTN1	3.53e-05	3	120	2	26264903
Pubmed	Netrin/DCC-mediated attraction of vagal sensory axons to the fetal mouse gut.	DCC NTN1	3.53e-05	3	120	2	16917820
Pubmed	PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha.	NRF1 PPARGC1B	3.53e-05	3	120	2	20561910
Pubmed	Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.	NRF1 PPARGC1B	3.53e-05	3	120	2	12832613
Pubmed	Maintenance of axo-oligodendroglial paranodal junctions requires DCC and netrin-1.	DCC NTN1	3.53e-05	3	120	2	18945908
Pubmed	Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.	IGF1R CD44	3.53e-05	3	120	2	29892839
Pubmed	Role of PKR and Type I IFNs in viral control during primary and secondary infection.	IFNAR1 EIF2AK2	3.53e-05	3	120	2	20585572
Pubmed	The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms.	RBM10 AGGF1	3.53e-05	3	120	2	19508861
Pubmed	Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.	CSPG4 CD44	3.53e-05	3	120	2	28945172
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	DOC2A FLG ABI3BP NSD2 PARP8 SHB SANBR DCC GPALPP1 USP8 STARD9 CHD5 CSPG4 RIMS2 KIAA2012 BAHCC1	3.75e-05	1442	120	16	35575683
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 MIA3 ERCC6L GPATCH8 YEATS2 USP8 ZNF451 ROCK1 TTC17 CLSPN PCM1	4.90e-05	733	120	11	34672954
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	NRIP1 RBM10 EFEMP2 KAT6A GPATCH8 XRCC4 BEND2 ZNF804A GRIP2 ZNF639	5.14e-05	608	120	10	16713569
Pubmed	Dynamic FoxG1 expression coordinates the integration of multipolar pyramidal neuron precursors into the cortical plate.	DSCAM DCC NTN1	5.88e-05	22	120	3	22726835
Pubmed	Draxin from neocortical neurons controls the guidance of thalamocortical projections into the neocortex.	DSCAM DCC CSPG4	6.75e-05	23	120	3	26659141
Pubmed	The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling.	CSPG4 GRIP2	7.05e-05	4	120	2	12458226
Pubmed	Netrin binds discrete subdomains of DCC and UNC5 and mediates interactions between DCC and heparin.	DCC NTN1	7.05e-05	4	120	2	12810718
Pubmed	CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes.	PTPRC CD44	7.05e-05	4	120	2	9573028
Pubmed	Deleted in colorectal cancer (DCC) regulates the migration of luteinizing hormone-releasing hormone neurons to the basal forebrain.	DCC NTN1	7.05e-05	4	120	2	11157077
Pubmed	Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.	IFNAR1 PTPRC	7.05e-05	4	120	2	30540940
Pubmed	Focal adhesion kinase in netrin-1 signaling.	DCC NTN1	7.05e-05	4	120	2	15494733
Pubmed	Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.	IFNAR1 PTPRC	7.05e-05	4	120	2	9403695
Pubmed	Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.	CDC42BPA ROCK1	7.05e-05	4	120	2	17344417
Interaction	SNRNP40 interactions	MAGEA6 NSD2 RBM10 KAT6A WRN AGGF1 GPATCH8 RFC1 EMSY GPALPP1 ZNF462 YEATS2 ZNF451 SLBP ZFHX3	5.28e-06	637	119	15	int:SNRNP40
GeneFamily	BEN domain containing	NACC1 BEND2 NACC2	7.68e-06	9	83	3	422
GeneFamily	Fibronectin type III domain containing	SDK2 DSCAM ABI3BP DCC CMYA5 IGF1R PTPRC	8.80e-06	160	83	7	555
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	RBM10 AGGF1 GPATCH8	1.35e-04	22	83	3	579
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	CSPG4 CD44	4.31e-04	7	83	2	570
GeneFamily	PHD finger proteins	NSD2 KAT6A CHD5 SHPRH	7.82e-04	90	83	4	88
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 DSCAM DCC SIGLEC11 ALPK2	8.73e-04	161	83	5	593
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF26A KIF26B STARD9	1.23e-03	46	83	3	622
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL3 OSBPL6	1.33e-03	12	83	2	670
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 NRIP1 CDC42BPA KAT6A SHB WRN SPECC1L GPATCH8 INPP5F XRCC4 ZNF804A IGF1R ZNF451 RIN2 ROCK1 ZFHX3 MN1 DOP1B	7.13e-08	856	120	18	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	FNBP1 MIA3 ANK3 DSCAM APC2 AFF3 FRS3 ARHGEF12 DCC ZNF462 PPARGC1B CHD5 OSBPL6 ZFHX3 ANKRD12 GRIP2 RIMS2 MAPK8IP2 DOP1B	6.67e-07	1106	120	19	M39071
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FNBP1 USP34 ERCC6L NSD2 GPR37 CCDC18 SANBR INPP5F PPM1A IGF1R SNX10 OSBPL6 SMARCB1 KIAA1958 CLSPN EDRF1	3.22e-06	892	120	16	M18120
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9	KAT6A WRN PCM1	5.15e-06	8	120	3	M9239
Coexpression	DESCARTES_ORGANOGENESIS_NOTOCHORD_CELLS	DCHS2 HEY1 KIAA1958 NTN1 KIAA2012	8.96e-06	61	120	5	MM3633
Coexpression	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	FNBP1 DIS3L2 RFC1 USP8 APPL2 ZFHX3 DOP1B	2.06e-05	181	120	7	M8662
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	USP34 ERCC6L NSD2 CCDC18 SANBR ALPK1 RALBP1	3.21e-05	194	120	7	M7467
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	FNBP1 NRIP1 CDC42BPA WRN AGGF1 RFC1 XRCC4 GPALPP1 USP8 RALBP1 SNX10 PCM1	4.92e-05	656	120	12	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NRIP1 CDC42BPA KAT6A SHB WRN SPECC1L INPP5F XRCC4 ZNF804A DOP1B	5.82e-05	466	120	10	M13522
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	BNC2 ABI3BP AFF3 ZNF451 RIN2 NTN1 ANKRD12 MN1 ZFP62	3.37e-05	288	118	9	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	NRIP1 BNC2 NSD2 GPR37 RFC1 PPM1A IFNAR1 FAM204A APPL2 ZNF451 SHPRH ROCK1 ZFHX3 ANKRD12 ZFP62	3.98e-05	804	118	15	gudmap_developingGonad_e12.5_ovary_1000
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK3 AFF3 SYNDIG1 CMYA5 IGF1R NTN1 GRIP2 ALPK2	4.51e-08	188	120	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM KIF26B PARP8 DCC ZNF804A CSPG4 NTN1 RIMS2	7.27e-08	200	120	8	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM KIF26B PARP8 DCC ZNF804A CSPG4 NTN1 RIMS2	7.27e-08	200	120	8	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM KIF26B PARP8 DCC ZNF804A CSPG4 NTN1 RIMS2	7.27e-08	200	120	8	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM KIF26B PARP8 DCC ZNF804A CSPG4 NTN1 RIMS2	7.27e-08	200	120	8	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM KIF26B PARP8 DCC ZNF804A CSPG4 NTN1 RIMS2	7.27e-08	200	120	8	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM KIF26B PARP8 DCC ZNF804A CSPG4 NTN1 RIMS2	7.27e-08	200	120	8	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 ANK3 KIF26B SYNDIG1 DCC ZNF462 ALPK2	7.39e-07	186	120	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANK3 PARP8 PTPRC CD44 SLBP ANKRD12 MN1	1.05e-06	196	120	7	ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BNC2 CDC42BPA ABI3BP AFF3 RIN2 CSPG4 MN1	1.09e-06	197	120	7	3fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 BNC2 ANK3 PARP8 ZNF451 ANKRD12 PCM1	1.16e-06	199	120	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	NRIP1 SERBP1 CDC42BPA SAMD15 RALBP1 ROCK1 ANKRD12	1.16e-06	199	120	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	NRIP1 CDC42BPA PARP8 RALBP1 ROCK1 ANKRD12	2.05e-06	138	120	6	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	droplet-Kidney-nan-24m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 LAIR1 PFKFB4 CMYA5 PTPRC CD44	6.15e-06	167	120	6	2ee1660be117e20f24557522345572d11cbee813
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ERCC6L KIF26A CCDC18 RASL12 DCAF16 CLSPN	7.53e-06	173	120	6	20889aa85e36ad3bafdb91b91e43964493c949f9
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ERCC6L KIF26A CCDC18 RASL12 DCAF16 CLSPN	7.53e-06	173	120	6	46e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 ANK3 PARP8 PTPRC OSBPL3 ANKRD12	9.75e-06	181	120	6	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ABI3BP SANBR AGGF1 SPECC1L SHPRH	1.21e-05	188	120	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ABI3BP SANBR AGGF1 SPECC1L SHPRH	1.21e-05	188	120	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ABI3BP SANBR AGGF1 SPECC1L SHPRH	1.21e-05	188	120	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 ABI3BP KIF26B SYNDIG1 DCC ALPK2	1.25e-05	189	120	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PFKFB4 SNX10 CD44 RIMS2 ALPK2	1.25e-05	189	120	6	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PFKFB4 SNX10 CD44 RIMS2 ALPK2	1.25e-05	189	120	6	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ANK3 SYNDIG1 CMYA5 NTN1 GRIP2 ALPK2	1.32e-05	191	120	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 KIF26B SYNDIG1 DCC ZNF462 ALPK2	1.32e-05	191	120	6	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 ANK3 ABI3BP SYNDIG1 ZNF804A NTN1	1.32e-05	191	120	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SDK2 ABI3BP KIF26B EFEMP2 RASL12	1.36e-05	192	120	6	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FNBP1 SDK2 LAIR1 ZNF428 MN1 BAHCC1	1.36e-05	192	120	6	38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SDK2 ABI3BP KIF26B EFEMP2 RASL12	1.36e-05	192	120	6	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP EFEMP2 STK33 PRRG3 MGARP MN1	1.44e-05	194	120	6	bbc625b4cc53bb7d6254fde287258e51f9171572
ToppCell	facs-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP EFEMP2 STK33 PRRG3 MGARP MN1	1.44e-05	194	120	6	fcd5e9238d299c41f0bf9693b56cd8c900d2112b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TOP6BL CMYA5 IGF1R STK33 KIAA1958	1.44e-05	194	120	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK3 SYNDIG1 CMYA5 IGF1R NTN1 ALPK2	1.44e-05	194	120	6	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SDK2 ABI3BP KIF26B RASL12 DCC	1.44e-05	194	120	6	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP EFEMP2 STK33 PRRG3 MGARP MN1	1.44e-05	194	120	6	6afc21c5fec30ab8e373e3e46ab7866204c805b6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ABI3BP TOP6BL OSBPL3 RALBP1 STK33	1.53e-05	196	120	6	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TOP6BL STK33 SNX10 CD44 RIMS2	1.58e-05	197	120	6	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 KAT6A LAIR1 PTPRC ZFHX3 PCM1	1.62e-05	198	120	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IFNAR1 PTPRC ROCK1 ANKRD12 EIF2AK2 PCM1	1.62e-05	198	120	6	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNBP1 FAM234B GPR37 TPRN ARSG APPL2	1.62e-05	198	120	6	43a2ce64fa309bac89a44ea320e87ae2cc39f782
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	FNBP1 ANK3 AFF3 PTPRC CD44 ANKRD12	1.62e-05	198	120	6	6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 KAT6A LAIR1 PTPRC ZFHX3 PCM1	1.62e-05	198	120	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ABI3BP RASL12 SPECC1L DCC STK33 MGARP	1.62e-05	198	120	6	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	NRIP1 CDC42BPA CCDC18 RALBP1 ROCK1 ANKRD12	1.62e-05	198	120	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 KAT6A LAIR1 PTPRC ZFHX3 PCM1	1.62e-05	198	120	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BNC2 SDK2 ABI3BP EFEMP2 RASL12 SPECC1L	1.67e-05	199	120	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Mild/Remission-B_intermediate-0\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ANK3 AFF3 ZNF804A CD44 SMARCB1 ANKRD12	1.67e-05	199	120	6	592111591f0f6816fc56620cb555eb48dabf0758
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	NRIP1 SERBP1 CDC42BPA RALBP1 ROCK1 ANKRD12	1.67e-05	199	120	6	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 PTPRC ROCK1 ANKRD12 EIF2AK2 PCM1	1.72e-05	200	120	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LILRB3 LAIR1 ZNF804A PPARGC1B PTPRC SNX10	1.72e-05	200	120	6	2f5b71e55c2de0e77fdae6667eb57f333acc6cd1
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LILRB3 PFKFB4 ZNF804A PPARGC1B PTPRC SNX10	1.72e-05	200	120	6	fc061de0db2e8b5ca47f5e2a1e861018e7f1b582
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_E\|390C / Donor, Lineage, Cell class and subclass (all cells)	NRIP1 AFF3 FRS3 PRMT9 EIF2AK2	6.30e-05	155	120	5	98d8432739965dd1ab77c899cb6321f7f05eaa46
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RASL12 SMIM31 HEY1 NTN1 MGARP	6.30e-05	155	120	5	8dab23aad905cc35a35643baa0554acb3f6fe6c8
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RASL12 SMIM31 HEY1 NTN1 MGARP	6.30e-05	155	120	5	42533beaded07068f00540de704de07e4f19abcf
ToppCell	PND07-28-samps\|World / Age Group, Lineage, Cell class and subclass	LILRB3 LAIR1 PTPRC SNX10 CD44	6.70e-05	157	120	5	a2005768a6d268879e3fd6dbd8cf674dc98be587
ToppCell	Myeloid\|World / shred on cell class and cell subclass (v4)	LILRB3 LAIR1 PTPRC SNX10 CD44	7.54e-05	161	120	5	aee407d3739dba2d5216dcdb1579e7e4f483123d
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	USP34 ANK3 KAT6A PTPRC ANKRD12	7.77e-05	162	120	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOC2A LILRB3 CCDC18 PTPRC ALPK2	7.77e-05	162	120	5	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 GPR37 PFKFB4 CD44 GRIP2	8.23e-05	164	120	5	8e6dbddacd56a07769163813e3ebfad13302bb62
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOC2A DSCAM CHD5 ANKRD12 GRIP2	8.71e-05	166	120	5	66026988509e39e41274fa0de738383219e8ff30
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	NRIP1 SDK2 AFF3 IGF1R BAHCC1	8.71e-05	166	120	5	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	NRIP1 SDK2 AFF3 IGF1R BAHCC1	8.96e-05	167	120	5	3ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSD2 LAIR1 CHD5 SNX10 CD44	9.22e-05	168	120	5	a1755afa2cc50960ba60e07d84d61be429cdea72
ToppCell	PND07-28-samps-Myeloid\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LILRB3 LAIR1 PTPRC SNX10 CD44	9.22e-05	168	120	5	87512f9e5e95333e7ffc6efa1e93bab2ba9154c6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 SDK2 SHB ALPK1 ZFHX3	9.22e-05	168	120	5	7abaddbcc55e44653d54aa15464266aa6bd5c9d2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFF3 CCDC18 LAIR1 PTPRC CLSPN	9.48e-05	169	120	5	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 SDK2 SHB ALPK1 ZFHX3	9.74e-05	170	120	5	417b77c12a7982b1ce4b4bc57f30335d261220f5
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PARP8 KAT6A PTPRC ANKRD12 PCM1	1.00e-04	171	120	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RFC1 PPARGC1B CSPG4 SLBP CLSPN	1.03e-04	172	120	5	03a0aff6b7971093a4347b5ed12546d78374c56f
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PFKFB4 PTPRC CHD5 SNX10 CD44	1.03e-04	172	120	5	584af6537685cb459bf0fc298e6f46872016c116
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	BNC2 ABI3BP KIF26B SYNDIG1 ALPK2	1.03e-04	172	120	5	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SANBR IGF1R OSBPL3 CHD5 KIAA2012	1.06e-04	173	120	5	53e97835d7a518c278e7b90a0734eb0095d6aa33
ToppCell	droplet-Lung-LUNG-1m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SANBR IGF1R OSBPL3 CHD5 KIAA2012	1.06e-04	173	120	5	889a880de5fc19d26b82cfef3067869a28ef17ca
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOC2A PFKFB4 PPARGC1B SNX10 CD44	1.18e-04	177	120	5	67cc3a6461db5e0678f96b18224aeb83ad34b0f4
ToppCell	facs-Lung-EPCAM-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNBP1 LILRB3 PTPRC SNX10 CD44	1.21e-04	178	120	5	01c90c3952220cc4d6a7ed9c4d575fe4f2f80fd1
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	NRF1 PFKFB4 ARSG GPALPP1 EIF2AK2	1.24e-04	179	120	5	9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	BNC2 DCHS2 ABI3BP KIF26B ALPK2	1.24e-04	179	120	5	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|COVID-19_Convalescent / Disease condition and Cell class	NRF1 PFKFB4 ARSG GPALPP1 EIF2AK2	1.24e-04	179	120	5	366e4a31db9e80fd1770ac9f1ae148fefeb9f7df
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BNC2 ABI3BP SYNDIG1 RASL12 NTN1	1.31e-04	181	120	5	25915e2500430a902db37d79a749ce2990b69810
ToppCell	PBMC-Control-cDC_12\|Control / Compartment, Disease Groups and Clusters	NSD2 SLBP NTN1 CLSPN RIMS2	1.34e-04	182	120	5	4774066d0f9986abc3d13a2a3bc99ce4f1327ae0
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 CMYA5 XRCC4 RNF216 ALPK2	1.34e-04	182	120	5	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DSCAM ZNF462 RIN2 CSPG4 NTN1	1.34e-04	182	120	5	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DSCAM ZNF462 RIN2 CSPG4 NTN1	1.34e-04	182	120	5	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	WRN INPP5F XRCC4 YEATS2 SNX10	1.38e-04	183	120	5	310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 SDK2 SHB ALPK1 ZFHX3	1.38e-04	183	120	5	65f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASL12 CSPG4 ZFHX3 GRIP2 MN1	1.41e-04	184	120	5	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASL12 CSPG4 ZFHX3 GRIP2 MN1	1.41e-04	184	120	5	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASL12 PPARGC1B CSPG4 GRIP2 RIMS2	1.41e-04	184	120	5	f4344f3c407b2d4d703fe56e43d84dbfe60ba833
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	PTPRC OSBPL3 SHPRH TTC17 DOP1B	1.45e-04	185	120	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 ANK3 ABI3BP DCC NTN1	1.45e-04	185	120	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BNC2 ABI3BP DCC STARD9 ZFHX3	1.45e-04	185	120	5	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 ABI3BP SYNDIG1 DCC NTN1	1.45e-04	185	120	5	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 ANK3 ABI3BP DCC NTN1	1.48e-04	186	120	5	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	PTPRC OSBPL3 SHPRH TTC17 DOP1B	1.48e-04	186	120	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DSCAM APC2 ZNF804A RIMS2 MAPK8IP2	1.48e-04	186	120	5	cf96f880e6e22189593ce1357c55e65c34644559
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 RALBP1 ROCK1 ANKRD12 PCM1	1.52e-04	187	120	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BNC2 ABI3BP DCC STARD9 ZFHX3	1.52e-04	187	120	5	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 DCC ZNF462 IGF1R ALPK2	1.52e-04	187	120	5	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TOP6BL RALBP1 STK33 NTN1	1.52e-04	187	120	5	2d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	CMYA5 PPARGC1B STK33 GRIP2 ALPK2	1.52e-04	187	120	5	78cdcf8bc141d3b155c3c8af908431fc419c4d08
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ANK3 NSD2 KAT6A ARHGEF12 TOP6BL ZNF428 DCAF16 RNF216	7.51e-06	191	119	8	4811_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A	CDC42BPA ANK3 DSCAM FRS3 ZNF428 PPM1A RIMS2 BAHCC1	9.07e-06	196	119	8	2207_UP
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A	CDC42BPA SZT2 KAT6A ARHGEF12 ZNF428 EMSY RIN2 CD44	9.07e-06	196	119	8	3259_UP
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	FNBP1 ANK3 ABI3BP NSD2 ARHGEF12 CHD1L IGF1R RNF216	9.07e-06	196	119	8	2080_UP
Drug	Lymecycline [992-21-2]; Down 200; 6.6uM; MCF7; HT_HG-U133A	CDC42BPA ABI3BP GPR37 SHB EMSY FAM204A RNF216 PCM1	9.41e-06	197	119	8	5994_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A	USP34 CDC42BPA XRCC4 GPALPP1 IGF1R ANKRD12 PCM1 BAHCC1	9.41e-06	197	119	8	1282_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	NRIP1 CDC42BPA AGGF1 DCAF16 PPM1A RALBP1 CD44	4.26e-05	178	119	7	3998_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	NRIP1 CDC42BPA DCAF16 PPM1A IGF1R RALBP1 ANKRD12	5.43e-05	185	119	7	1673_DN
Drug	troglitazone; Down 200; 10uM; PC3; HT_HG-U133A	FAM234B CDC42BPA ABI3BP GPR37 XRCC4 IFNAR1 GPALPP1	6.22e-05	189	119	7	1232_DN
Drug	Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A	EFEMP2 AGGF1 ALPK1 XRCC4 HEY1 RIN2 MN1	6.43e-05	190	119	7	6680_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	CDC42BPA ABI3BP AGGF1 ALPK1 GPATCH8 DCAF16 PCM1	6.65e-05	191	119	7	6020_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	BNC2 PFKFB4 DCC HEY1 OSBPL3 CHD5 CD44	6.87e-05	192	119	7	5575_UP
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; PC3; HT_HG-U133A	FNBP1 USP34 KAT6A FRS3 ALPK1 ZFHX3 PCM1	7.10e-05	193	119	7	5050_DN
Drug	Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A	CDC42BPA NSD2 SHB OSBPL3 RNF216 PCM1 BAHCC1	7.33e-05	194	119	7	2433_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; HL60; HG-U133A	FNBP1 NRIP1 ALPK1 XRCC4 IGF1R PCM1 BAHCC1	7.33e-05	194	119	7	1404_UP
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; HL60; HT_HG-U133A	USP34 NRF1 NSD2 CHD1L XRCC4 GPALPP1 APPL2	7.57e-05	195	119	7	1270_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A	NRF1 SZT2 KAT6A ZNF428 XRCC4 RIN2 EDRF1	7.57e-05	195	119	7	3269_UP
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	CDC42BPA DSCAM RBM10 ZNF428 YEATS2 SNX10 CD44	7.82e-05	196	119	7	610_DN
Drug	Nicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A	ABI3BP NSD2 ARHGEF12 EMSY HEY1 CD44 PCM1	7.82e-05	196	119	7	2058_UP
Drug	Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A	USP34 FAM234B NRF1 ARHGEF12 XRCC4 PCM1 ZNF639	8.07e-05	197	119	7	6570_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DOC2A USP34 MIA3 NRF1 IFNAR1 PCM1 ZNF639	8.07e-05	197	119	7	5025_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A	FAM234B FRS3 ARHGEF12 ZNF428 IGF1R ZFHX3 EDRF1	8.07e-05	197	119	7	5752_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MIA3 ANK3 XRCC4 CD44 TTC17 PCM1 ZNF639	8.07e-05	197	119	7	5463_DN
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DOC2A ALPK1 ZNF428 CD44 RIMS2 EDRF1 PCM1	8.07e-05	197	119	7	3894_DN
Drug	Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A	FNBP1 CDC42BPA GPR37 ARHGEF12 CD44 TTC17 PCM1	8.07e-05	197	119	7	6251_DN
Drug	Suramin sodium salt; Up 200; 10uM; PC3; HT_HG-U133A	FNBP1 FAM234B CHD1L GPALPP1 USP8 DOP1B BAHCC1	8.07e-05	197	119	7	7529_UP
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	DOC2A USP34 CDC42BPA NRF1 KAT6A PCM1 MAPK8IP2	8.33e-05	198	119	7	3754_DN
Drug	paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A	DSCAM EFEMP2 GPATCH8 IFNAR1 RALBP1 CD44 PCM1	8.33e-05	198	119	7	640_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MIA3 ABI3BP SZT2 KAT6A TOP6BL ALPK1 XRCC4	8.33e-05	198	119	7	6053_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A	NRF1 AFF3 ZNF428 XRCC4 PPM1A FAM204A EDRF1	8.33e-05	198	119	7	6202_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; HL60; HT_HG-U133A	EFEMP2 ZNF428 XRCC4 CSPG4 EDRF1 MAPK8IP2 DOP1B	8.33e-05	198	119	7	2176_UP
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A	KAT6A ARHGEF12 SYNDIG1 PFKFB4 IFNAR1 RIMS2 ZNF639	8.60e-05	199	119	7	4334_UP
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; PC3; HT_HG-U133A	CDC42BPA GPR37 EFEMP2 AGGF1 ALPK1 EMSY BAHCC1	8.60e-05	199	119	7	6617_DN
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	NRF1 GPR37 SHB ALPK1 GPALPP1 NACC2 RNF216	8.60e-05	199	119	7	1210_DN
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A	ANK3 ABI3BP KAT6A FRS3 ZNF428 FAM204A BAHCC1	8.60e-05	199	119	7	5804_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ANK3 ZNF428 XRCC4 EMSY PPM1A CD44 ZFHX3	8.87e-05	200	119	7	1476_DN
Drug	testosterone enanthate	USP34 SERBP1 ANK3 EFEMP2 AGGF1 GPATCH8 PPM1A YEATS2 PPARGC1B IGF1R EIF2AK2	2.18e-04	575	119	11	ctd:C004648
Drug	lead titanate zirconate	DCC NTN1	2.68e-04	5	119	2	ctd:C065536
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NRIP1 BNC2 YEATS2 OSBPL3 ROCK1 ANKRD12	2.83e-04	171	119	6	7535_DN
Drug	Succimer	USP34 NRIP1 MIA3 SERBP1 CDC42BPA ANK3 ZNF804A IGF1R PTPRC STARD9 CD44 ROCK1 ANKRD12 CLSPN RIMS2 EIF2AK2 PCM1	3.08e-04	1264	119	17	ctd:D004113
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NRIP1 NSD2 XRCC4 PPM1A IGF1R ZFHX3	3.41e-04	177	119	6	7550_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	NRIP1 XRCC4 ZNF804A TCEAL1 RIN2 ZFHX3	3.51e-04	178	119	6	4444_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	NRIP1 CDC42BPA ANK3 GPATCH8 PPM1A RALBP1	3.62e-04	179	119	6	4585_DN
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	DSCAM NRF1 ERCC6L ARHGEF12 EDRF1 ZNF639	3.72e-04	180	119	6	5027_DN
Drug	Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	CDC42BPA SHB ALPK1 ZNF804A CD44 BAHCC1	3.72e-04	180	119	6	1477_UP
Drug	Nimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	BNC2 CDC42BPA ANK3 ABI3BP PFKFB4 CD44	4.31e-04	185	119	6	3103_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	MIA3 ANK3 DSCAM SZT2 EMSY CD44	4.43e-04	186	119	6	1664_UP
Drug	hexammineruthenium	IFNAR1 PPARGC1B PTPRC	4.61e-04	29	119	3	CID000124002
Drug	Magnetite Nanoparticles	USP34 NRIP1 MIA3 SERBP1 CDC42BPA ANK3 ZNF804A IGF1R PTPRC STARD9 CD44 ROCK1 ANKRD12 CLSPN RIMS2 EIF2AK2 PCM1	4.64e-04	1310	119	17	ctd:D058185
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	NRIP1 CDC42BPA AGGF1 DCAF16 PPM1A CD44	4.69e-04	188	119	6	6735_DN
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SZT2 NSD2 GPR37 PARP8 EIF2AK2 EDRF1	4.69e-04	188	119	6	5490_UP
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	USP34 NRF1 ALPK1 ZNF428 IFNAR1 EDRF1	4.82e-04	189	119	6	2790_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	NRIP1 BNC2 KAT6A AGGF1 ALPK1 IGF1R	4.82e-04	189	119	6	6649_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	NRIP1 FAM234B ABI3BP KAT6A AGGF1 IGF1R	5.10e-04	191	119	6	4279_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	CDC42BPA DCAF16 PPM1A IGF1R PCM1 ZNF639	5.24e-04	192	119	6	6435_DN
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; HL60; HT_HG-U133A	USP34 FAM234B NSD2 LAIR1 AGGF1 CHD1L	5.24e-04	192	119	6	1273_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	ERCC6L RBM10 SPECC1L YEATS2 RIN2 EIF2AK2	5.24e-04	192	119	6	458_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	SZT2 KAT6A ZNF428 EIF2AK2 EDRF1 ZNF639	5.39e-04	193	119	6	3250_UP
Drug	thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	AGGF1 CHD1L ZNF428 OSBPL3 PCM1 BAHCC1	5.39e-04	193	119	6	2690_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FNBP1 USP34 NSD2 KAT6A TTC17 PCM1	5.39e-04	193	119	6	4846_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A	FNBP1 CD44 ROCK1 ANKRD12 EIF2AK2 PCM1	5.39e-04	193	119	6	1412_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	USP34 MIA3 ANK3 ALPK1 ZNF428 PCM1	5.39e-04	193	119	6	3293_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	ANK3 ARHGEF12 ALPK1 PPM1A IGF1R PCM1	5.39e-04	193	119	6	4321_DN
Drug	Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A	ABI3BP EFEMP2 ARHGEF12 TOP6BL ALPK1 XRCC4	5.39e-04	193	119	6	5839_DN
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	KAT6A ARHGEF12 ZNF428 ZNF639 DOP1B BAHCC1	5.39e-04	193	119	6	5271_UP
Drug	Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	RIN2 CD44 EIF2AK2 EDRF1 MAPK8IP2 ZNF639	5.39e-04	193	119	6	7181_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HG-U133A	CDC42BPA DSCAM NSD2 RBM10 EFEMP2 DCAF16	5.54e-04	194	119	6	428_DN
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	DOC2A USP34 RIN2 TTC17 EDRF1 ZNF639	5.54e-04	194	119	6	862_UP
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	EFEMP2 ZNF428 XRCC4 CD44 ZFHX3 MAPK8IP2	5.54e-04	194	119	6	4599_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	NRF1 NSD2 ARHGEF12 RFC1 GPALPP1 CD44	5.54e-04	194	119	6	7283_DN
Drug	AC1L8SKE	PPARGC1B PTPRC CD44	5.62e-04	31	119	3	CID000386852
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	RBM10 KAT6A SHB TOP6BL XRCC4 RNF216	5.69e-04	195	119	6	6338_DN
Drug	WY-14643; Up 200; 100uM; MCF7; HG-U133A	DSCAM NRF1 NSD2 RBM10 SHB ANKRD12	5.69e-04	195	119	6	368_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SHB ALPK1 EMSY IFNAR1 CD44 ZNF639	5.69e-04	195	119	6	2810_DN
Drug	Acemetacin [53164-05-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	DSCAM ARHGEF12 SYNDIG1 EMSY EIF2AK2 MAPK8IP2	5.69e-04	195	119	6	2411_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	BNC2 CDC42BPA ANK3 SZT2 SHB ZNF428	5.69e-04	195	119	6	3124_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	NSD2 ARHGEF12 XRCC4 ZNF804A EMSY PCM1	5.69e-04	195	119	6	2064_UP
Drug	5194442; Up 200; 20uM; MCF7; HT_HG-U133A	DOC2A USP34 EMSY RALBP1 RNF216 ANKRD12	5.69e-04	195	119	6	6558_UP
Drug	Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	DSCAM SHB ZNF428 XRCC4 TCEAL1 ZFHX3	5.69e-04	195	119	6	6244_UP
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	CDC42BPA DSCAM GPR37 ALPK1 CSPG4 DOP1B	5.69e-04	195	119	6	5665_UP
Drug	rotenone; Up 200; 1uM; MCF7; HT_HG-U133A	DOC2A MIA3 ALPK1 XRCC4 FAM204A EDRF1	5.69e-04	195	119	6	5943_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	BNC2 XRCC4 IFNAR1 CD44 RIMS2 BAHCC1	5.84e-04	196	119	6	6483_UP
Drug	(+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A	DSCAM ALPK1 ZNF428 EMSY RIN2 PCM1	5.84e-04	196	119	6	6798_DN
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	NRF1 ZNF804A RIN2 CD44 ZFHX3 EDRF1	5.84e-04	196	119	6	5411_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	CDC42BPA ALPK1 RIMS2 EDRF1 PCM1 ZNF639	5.84e-04	196	119	6	3790_DN
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	USP34 CDC42BPA ALPK1 ZNF428 DCAF16 CD44	5.84e-04	196	119	6	3547_DN
Drug	Methylatropine nitrate [52-88-0]; Up 200; 11uM; HL60; HT_HG-U133A	BNC2 ABI3BP SZT2 XRCC4 CSPG4 EDRF1	5.84e-04	196	119	6	3116_UP
Drug	Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A	ALPK1 ZNF428 XRCC4 EMSY SMARCB1 BAHCC1	5.84e-04	196	119	6	6615_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A	ABI3BP FRS3 XRCC4 OSBPL3 RIMS2 ZNF639	5.84e-04	196	119	6	1505_UP
Drug	radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A	DOC2A CDC42BPA ALPK1 FAM204A RIMS2 EDRF1	5.84e-04	196	119	6	5947_UP
Drug	Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	CDC42BPA ARHGEF12 ALPK1 RIMS2 ZNF639 DOP1B	5.84e-04	196	119	6	3349_UP
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	FAM234B NRF1 ALPK1 XRCC4 RIMS2 ZNF639	5.84e-04	196	119	6	5022_DN
Drug	AH6809; Down 200; 1uM; PC3; HT_HG-U133A	USP34 ANK3 DSCAM SZT2 CHD1L ABRAXAS2	5.84e-04	196	119	6	7049_DN
Drug	Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A	DSCAM KAT6A CHD1L YEATS2 RNF216 TTC17	5.84e-04	196	119	6	7424_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	CDC42BPA DSCAM RFC1 XRCC4 EDRF1 BAHCC1	5.84e-04	196	119	6	1658_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A	CDC42BPA NRF1 NSD2 ALPK1 FAM204A BAHCC1	5.84e-04	196	119	6	2249_DN
Drug	NU1025; Down 200; 100uM; MCF7; HG-U133A	CDC42BPA DSCAM ARHGEF12 RALBP1 SNX10 RNF216	6.00e-04	197	119	6	608_DN
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	BNC2 APC2 FRS3 SYNDIG1 XRCC4 OSBPL3	6.00e-04	197	119	6	3925_UP
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; PC3; HT_HG-U133A	FAM234B FRS3 ZNF428 XRCC4 MN1 EDRF1	6.00e-04	197	119	6	3983_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A	TOP6BL RIN2 CD44 EDRF1 PCM1 ZNF639	6.00e-04	197	119	6	7411_UP
Disease	heel bone mineral density, urate measurement	AFF3 WRN CHD1L OSBPL3 RNF216 PCM1	9.43e-05	182	118	6	EFO_0004531, EFO_0009270
Disease	netrin-1 measurement	NTN1 PCM1	9.46e-05	4	118	2	EFO_0022009
Disease	complex cortical dysplasia with other brain malformations (is_implicated_in)	KIF26A APC2	9.46e-05	4	118	2	DOID:0090131 (is_implicated_in)
Disease	congenital mirror movement disorder (is_implicated_in)	DCC NTN1	9.46e-05	4	118	2	DOID:0111153 (is_implicated_in)
Disease	Drug habituation	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0013170
Disease	Drug abuse	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0013146
Disease	Prescription Drug Abuse	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C4316881
Disease	Substance-Related Disorders	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0236969
Disease	Drug Use Disorders	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0013222
Disease	Drug Dependence	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C1510472
Disease	Substance Dependence	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0038580
Disease	Substance Use Disorders	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	DSCAM AFF3 CHD1L ZNF804A APPL2	1.02e-04	115	118	5	C0029231
Disease	Substance abuse problem	DSCAM AFF3 CHD1L ZNF804A APPL2	1.06e-04	116	118	5	C0740858
Disease	Global developmental delay	SZT2 APC2 ZNF462 IGF1R MN1	2.01e-04	133	118	5	C0557874
Disease	peripheral neuropathy, response to bortezomib	DCC CMYA5	2.35e-04	6	118	2	EFO_0003100, EFO_0007808
Disease	meningioma (is_implicated_in)	SMARCB1 MN1	2.35e-04	6	118	2	DOID:3565 (is_implicated_in)
Disease	brain measurement, neuroimaging measurement	DCHS2 ANK3 KIF26B GPATCH8 DCC ZNF462 NTN1 ZFHX3 BAHCC1	3.77e-04	550	118	9	EFO_0004346, EFO_0004464
Disease	childhood onset asthma	FLG MIA3 ABI3BP SYNDIG1 EMSY PTPRC KIAA1958	4.03e-04	334	118	7	MONDO_0005405
Disease	twisted gastrulation protein homolog 1 measurement	RALBP1 ANKRD12	4.37e-04	8	118	2	EFO_0803205
Disease	atrial fibrillation	USP34 SANBR ALPK1 ZNF462 IGF1R ZFHX3 PCM1	7.50e-04	371	118	7	EFO_0000275
Disease	thrombin-antithrombin complex measurement	GPR37 PTPRC	1.02e-03	12	118	2	EFO_0007775
Disease	neuroimaging measurement	DCHS2 CDC42BPA ANK3 SZT2 KIF26B AFF3 ARHGEF12 DCC XRCC4 ZNF462 NTN1 BAHCC1	1.21e-03	1069	118	12	EFO_0004346
Disease	nephroblastoma (is_implicated_in)	DIS3L2 IGF1R	1.40e-03	14	118	2	DOID:2154 (is_implicated_in)
Disease	lobe attachment	BNC2 SHPRH NTN1 MN1 EIF2AK2	1.49e-03	207	118	5	EFO_0007667
Disease	Down syndrome (implicated_via_orthology)	DSCAM DOP1B	1.61e-03	15	118	2	DOID:14250 (implicated_via_orthology)
Disease	chronic obstructive pulmonary disease	BNC2 DCHS2 TPRN AFF3 SHB EMSY PPARGC1B MN1 PCM1	1.81e-03	688	118	9	EFO_0000341
Disease	Fetal Alcohol Syndrome	ANK3 ERCC6L	2.07e-03	17	118	2	C0015923
Disease	Intellectual Disability	NSD2 APC2 AFF3 SPECC1L DCC ZNF462 MN1	2.18e-03	447	118	7	C3714756
Disease	biological sex	CDC42BPA ANK3 AFF3 DCC RIMS2	2.36e-03	230	118	5	PATO_0000047
Disease	Lewy body dementia (is_marker_for)	GPR37 IGF1R	2.59e-03	19	118	2	DOID:12217 (is_marker_for)
Disease	Meningioma	WRN SMARCB1	2.59e-03	19	118	2	C0025286
Disease	Craniosynostosis	ZNF462 MN1	2.87e-03	20	118	2	C0010278
Disease	Fetal Growth Retardation	NSD2 IGF1R	2.87e-03	20	118	2	C0015934
Disease	freckles	BNC2 PPARGC1B	2.87e-03	20	118	2	EFO_0003963
Disease	serum non-albumin protein measurement	MIA3 NACC1 KAT6A AFF3 USP8 SMARCB1	3.36e-03	361	118	6	EFO_0004568
Disease	Paroxysmal atrial fibrillation	USP34 ZNF462 IGF1R ZFHX3	3.62e-03	156	118	4	C0235480
Disease	familial atrial fibrillation	USP34 ZNF462 IGF1R ZFHX3	3.62e-03	156	118	4	C3468561
Disease	unipolar depression, bipolar disorder	ANK3 DCC OSBPL3 STARD9	3.62e-03	156	118	4	EFO_0003761, MONDO_0004985
Disease	Persistent atrial fibrillation	USP34 ZNF462 IGF1R ZFHX3	3.62e-03	156	118	4	C2585653
Disease	Huntington's disease (is_implicated_in)	NRF1 EIF2AK2	3.80e-03	23	118	2	DOID:12858 (is_implicated_in)
Disease	Malignant neoplasm of breast	NRIP1 NSD2 APC2 PFKFB4 EMSY PPARGC1B IGF1R PTPRC HEY1 CHD5 CLSPN	3.90e-03	1074	118	11	C0006142
Disease	Atrial Fibrillation	USP34 ZNF462 IGF1R ZFHX3	3.96e-03	160	118	4	C0004238

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSDSDLESEQEEYPL	AFF3	676	P51826
SDNEDSSYSSDDEDP	BAHCC1	2371	Q9P281
DSDDSDYENLIDPTE	ABRAXAS2	371	Q15018
QSPAYSSVDTEETIE	PRMT9	336	Q6P2P2
VYQHDDSETTEDDIP	CSPG4	971	Q6UVK1
SDNQSEYSIGSEDED	CHD5	1366	Q8TDI0
NEYNESSESEVSPTP	BNC2	361	Q6ZN30
QEPERDYENESESSE	BNC2	716	Q6ZN30
SPQLSSEDSDSDYEL	ALPK2	296	Q86TB3
DSECSEVYQPLTSSD	SPECC1L	346	Q69YQ0
SQTEDSYDEAITSEG	AGGF1	376	Q8N302
DNISSADYTQDPSVT	ARSG	496	Q96EG1
SSVSQDSDSEAYPED	FLG	3861	P20930
SNSNSETEEEEEPYG	DNHD1	2721	Q96M86
ESYTDSEEAQSVNPS	ANKRD12	311	Q6UB98
PESNDKETEAAYESD	DIS3L2	126	Q8IYB7
TETESNVNAYEECPS	FAM204A	56	Q9H8W3
SEEEENISYLNESSG	DCAF16	16	Q9NXF7
QDVETETEPSDYSNG	ALPK1	551	Q96QP1
YDPVQESSTDEEVAS	ARHGEF12	1421	Q9NZN5
TAASSVEEPEDCDSY	NTN1	461	O95631
ISEYDPNLEDTYSSE	RASL12	46	Q9NYN1
PNLEDTYSSEETVDH	RASL12	51	Q9NYN1
ESTNLEDYEPNTVAS	RALBP1	251	Q15311
SEEQSAEDSYEASPG	RBM10	61	P98175
YVESSEESSDEQPDE	PAGE1	16	O75459
YSDLDQSNVTEETPE	SERBP1	246	Q8NC51
YTAETPENDLDESQV	DCC	711	P43146
PDNTYVSSSENDEDV	PARP8	61	Q8N3A8
SQSYEDSSNQEEEGP	MAGEA3	81	P43357
SQSYEDSSNQEEEGP	MAGEA6	81	P43360
ENSESPLNENSDESY	EDRF1	521	Q3B7T1
PLNENSDESYSEEEE	EDRF1	526	Q3B7T1
VPESEISNSYEDQSS	DOP1B	311	Q9Y3R5
DPDYSSSSEQSCDTV	KIF26B	851	Q2KJY2
STYNDTEDVSQASPS	LAIR1	66	Q6GTX8
DTNSEYESGSESEPD	MAPK8IP2	326	Q13387
YESGSESEPDLSEDA	MAPK8IP2	331	Q13387
DIADDSTYVTADNPT	BEND2	41	Q8NDZ0
NTTAADTYNITDPEE	IGF1R	756	P08069
KSPSQYSEEEEEEDS	GPATCH8	831	Q9UKJ3
GNYSNEDESESKTSE	IFNAR1	536	P17181
EESEYDSEHENSEPV	PCM1	531	Q15154
EYDPLTQADSDESED	FAM234B	21	A2RU67
SPDYVNRDSDEATED	PFKFB4	176	Q16877
PSESPYESADETQTE	NSD2	636	O96028
DEDSPSSPEDTSYDD	NRF1	41	Q16656
SSPEDTSYDDSDILN	NRF1	46	Q16656
SGPDVSYEETEDTSN	KIAA2012	901	Q0VF49
EESSTPTTIDEYSDN	NRIP1	406	P48552
DPDYSSSSEQSCDTV	KIF26A	776	Q9ULI4
DTEAAASEASQDVTY	LILRB3	581	O75022
ESYISDVSDNISEDN	OSBPL6	516	Q9BZF3
DEGNNAEVTYSVSSE	DCHS2	1326	Q6V1P9
SEEELASTPEYTSCD	RIMS2	546	Q9UQ26
IESTTENYENPSSYD	KAT6A	1556	Q92794
DATPSSSSENYVQET	APC2	1141	O95996
DDNDNEYTTELELSP	GPR37	581	O15354
TTPEDGAEVDSYDSD	DOC2A	71	Q14183
EDIYPSNPTDDDVSS	CD44	166	P16070
DYDPETSDDSLESSD	EIF2AK2	331	P19525
TSDDSLESSDYDPEN	EIF2AK2	336	P19525
ESPDGSYTEEQSQES	FNBP1	516	Q96RU3
EELSSVSPSENSDYA	CCDC18	41	Q5T9S5
DEQSHTYVNTPASED	FRS3	186	O43559
DTEEAELFSPDSASQ	CMYA5	991	Q8N3K9
EESSAELDYQDPDAT	CHD1L	701	Q86WJ1
EDSSSLYEEGNQESE	GPALPP1	51	Q8IXQ4
GADVSDSSDDESIYQ	ANK3	3311	Q12955
SVDESVYTPDSDVAA	APPL2	256	Q8NEU8
TSDEYAELEEENSPA	MGARP	201	Q8TDB4
PEYSSSDSELDETIE	HEY1	6	Q9Y5J3
EEPQNYTDSSSSSTE	EMSY	711	Q7Z589
EDNSDELETTGAVSY	GRIP2	641	Q9C0E4
SPQDSEEPDSYTECT	EFEMP2	26	O95967
LNVSEECSYSDPSES	SAMD15	486	Q9P1V8
ECSYSDPSESQTELS	SAMD15	491	Q9P1V8
ISDSQGSDSEYEVDS	SDK2	2051	Q58EX2
VNYTESSDDEKSSPE	INPP5F	246	Q9Y2H2
YTEEDPSGETLSSEN	ERCC6L	1141	Q2NKX8
PSSSENEISDDDSYV	OSBPL3	461	Q9H4L5
SDEVSTSYANEDEVS	MN1	1046	Q10571
KESDSYSVSPSQDTD	DSCAM	1781	O60469
LSDVDTVNPDEDSFS	SZT2	1531	Q5T011
YEPEGQSVDSDSEST	SHB	301	Q15464
DANYTSDEEEEKQST	STK33	436	Q9BYT3
SSEPQTSSQDDFDVY	SLBP	221	Q14493
PDVSYQVESSEEDQS	TOP6BL	301	Q8N6T0
FQELESDYSSDTESE	SYNDIG1	156	Q9H7V2
PVEANSEESDSVFSE	MIA3	181	Q5JRA6
STSPSLDSEYNEELN	RFC1	1086	P35251
ENSETEPNQYSPDDS	PPARGC1B	66	Q86YN6
ASIYTTPDDSNEEEE	SMIM31	26	A0A1B0GVY4
TDSEYLPSDTSDDDD	SHPRH	546	Q149N8
ESYPTDSILEDQSDQ	SMARCB1	246	Q12824
YTESDPLETQNQSSE	RNF216	131	Q9NWF9
SPNDNENDTSYVIES	WRN	426	Q14191
AESQVEPSYSEQADS	STARD9	1306	Q9P2P6
QSLFSEEEEYTTGSE	SANBR	551	Q6NSI8
EVSSPTDTSNFDVDD	CDC42BPA	361	Q5VT25
PTVTSDDCNQDDDSY	CCDC54	46	Q8NEL0
DTNASPEKTTYDSAE	CLSPN	71	Q9HAW4
SDSEYTLSEPDSEEE	ZNF428	31	Q96B54
EQSSEEQSSEEEFFP	TCEAL1	36	Q15170
DTNSSLEDYEGESDQ	RIN2	456	Q8WYP3
SDDEEPSTSYTDENI	ZNF451	51	Q9Y4E5
AISEDYDIETENNSS	ZNF639	146	Q9UID6
NPYKNDDTDSTSTDD	PPM1A	366	P35813
DPVYDESTDEESENQ	XRCC4	226	Q13426
LSSDDYSTEEEAQTP	TTC17	536	Q96AE7
YSTEEEAQTPDCSIT	TTC17	541	Q96AE7
ENDIDYDSESSSSGL	SNX10	166	Q9Y5X0
VPDLSSDIDTSNFDD	ROCK1	356	Q13464
QTTFEYPSESSLEQE	TPRN	586	Q4KMQ1
TSTEDEEPTEEYENV	ZFP62	6	Q8NB50
EEVEDSNDSSYSEPP	ZNF462	2136	Q96JM2
YPDSDDSSEDQVENS	USP34	1466	Q70CQ2
SDEPEISDSYTATSD	ABI3BP	391	Q7Z7G0
DDDSDSEEPSKYINA	PTPRC	1006	P08575
QESSSEEASVSYSDP	PRRG3	201	Q9BZD7
SYSSPDITQAIQEEE	USP8	716	P40818
EPADQEAPSTTEYSE	SIGLEC11	656	Q96RL6
EDCIYPQSSESDISD	YEATS2	336	Q9ULM3
PTDDYSEESDTDLSQ	ZFHX3	3656	Q15911
TTVAEDPESANNYTA	ZNF804A	181	Q7Z570
SSVTDEDSDFEPQTQ	KIAA1958	151	Q8N8K9
TSDSPGSYHNEEDEE	NACC1	271	Q96RE7
TTDSPTSYHNEEDEE	NACC2	256	Q96BF6